Evald Høj Christiansen

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. doi request reprint Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial
    Evald Høj Christiansen
    Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
    Lancet 381:661-9. 2013
  2. ncbi request reprint Transient coronary aneurysm formation after Nevo™ stent implantation versus persistent coronary aneurysm after Cypher Select™ stent implantation
    Evald Høj Christiansen
    Department of Cardiology, University of Aarhus, Skejby Hospital, Denmark
    J Invasive Cardiol 23:E158-60. 2011
  3. doi request reprint Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark
    Am J Cardiol 109:629-35. 2012
  4. doi request reprint Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial)
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Am J Cardiol 110:1585-91. 2012
  5. doi request reprint 2-year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    J Am Coll Cardiol 60:1140-7. 2012
  6. doi request reprint Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV)
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark
    Circulation 125:1246-55. 2012
  7. pmc Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)
    Troels Thim
    Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
    BMC Cardiovasc Disord 12:18. 2012
  8. pmc Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry
    Michael Maeng
    Department of Cardiology, Aarhus University Hospital, Skejby, Brendstrupgaardsvej 100, 8200 Aarhus N, Denmark
    BMC Cardiovasc Disord 12:84. 2012
  9. doi request reprint Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
    Klaus Rasmussen
    Department of Cardiology, Aarhus University Hospital, Aalborg Hospital, Aalborg, Denmark
    Lancet 375:1090-9. 2010
  10. doi request reprint 3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents
    Michael Maeng
    Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
    JACC Cardiovasc Interv 5:812-8. 2012

Collaborators

Detail Information

Publications15

  1. doi request reprint Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial
    Evald Høj Christiansen
    Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
    Lancet 381:661-9. 2013
    ..We aimed to further investigate the effects of a biodegradable polymer biolimus-eluting stent compared with a durable polymer-coated sirolimus-eluting stent in a population-based setting...
  2. ncbi request reprint Transient coronary aneurysm formation after Nevo™ stent implantation versus persistent coronary aneurysm after Cypher Select™ stent implantation
    Evald Høj Christiansen
    Department of Cardiology, University of Aarhus, Skejby Hospital, Denmark
    J Invasive Cardiol 23:E158-60. 2011
    ..We hypothesize that aneurysm formation was induced by sirolimus and the polymer of the implanted stents, and that subsequent healing was possible in the Nevo stent after degradation of the polymer...
  3. doi request reprint Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark
    Am J Cardiol 109:629-35. 2012
    ..03, 95% CI 1.59 to 2.59). In conclusion, stent thrombosis rate was similar in patients with and without DM and STEMI treated with primary PCI, whereas the presence of DM increased the risk of MI, TLR, and death...
  4. doi request reprint Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial)
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Am J Cardiol 110:1585-91. 2012
    ..In conclusion, patients with diabetes have higher MACE rates than nondiabetics. No significant differences in safety or efficacy outcomes after EES or SES implantation were present in nondiabetic or diabetic patients...
  5. doi request reprint 2-year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    J Am Coll Cardiol 60:1140-7. 2012
    ..There are limited head-to-head randomized data on patient-related versus stent-related outcomes for everolimus-eluting stents (EES) and sirolimus-eluting stents (SES)...
  6. doi request reprint Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV)
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark
    Circulation 125:1246-55. 2012
    ..Among drug-eluting stents released to date, the sirolimus-eluting stent has demonstrated the least amount of late lumen loss, but its efficacy and safety have not been compared head-to-head with the next-generation everolimus-eluting stent...
  7. pmc Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)
    Troels Thim
    Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
    BMC Cardiovasc Disord 12:18. 2012
    ..However, a separate comparison of clinical outcome among patients treated for multiple lesions with these stents is lacking. We performed this comparison within the SORT OUT III trial data set...
  8. pmc Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry
    Michael Maeng
    Department of Cardiology, Aarhus University Hospital, Skejby, Brendstrupgaardsvej 100, 8200 Aarhus N, Denmark
    BMC Cardiovasc Disord 12:84. 2012
    ..We evaluated the effectiveness and safety of a zotarolimus-eluting (ZES) versus a sirolimus-eluting (SES) coronary stent in a large cohort of patients treated with one of these stents in Western Denmark...
  9. doi request reprint Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
    Klaus Rasmussen
    Department of Cardiology, Aarhus University Hospital, Aalborg Hospital, Aalborg, Denmark
    Lancet 375:1090-9. 2010
    ..We compared the efficacy and safety of the zotarolimus-eluting stent versus the sirolimus-eluting stent in patients with coronary artery disease who were receiving routine clinical care with no direct follow-up...
  10. doi request reprint 3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents
    Michael Maeng
    Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
    JACC Cardiovasc Interv 5:812-8. 2012
    ....
  11. doi request reprint Comparison of outcomes of patients ≥ 80 years of age having percutaneous coronary intervention according to presentation (stable vs unstable angina pectoris/non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction)
    Lisbeth Antonsen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Am J Cardiol 108:1395-400. 2011
    ..Patients with SAP had the lowest mortality rates and rates of clinically driven target vessel revascularization decreased over time...
  12. doi request reprint Scintigraphic evaluation of routine filterwire distal protection in percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: a randomized controlled trial
    Anne Kaltoft
    Department of Cardiology B, Aarhus University Hospital, Skejby, 8200, Aarhus N, Denmark
    J Nucl Cardiol 16:784-91. 2009
    ..In a prospective randomized trial, we assessed the effect of routine filterwire distal protection on scintigraphic estimated infarct size...
  13. doi request reprint Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial
    Hans Erik Bøtker
    Department of Cardiology, Aarhus University Hospital Skejby, Aarhus N, Denmark
    Lancet 375:727-34. 2010
    ..We tested the hypothesis that remote ischaemic conditioning during evolving ST-elevation myocardial infarction, and done before primary percutaneous coronary intervention, increases myocardial salvage...
  14. ncbi request reprint Coronary artery bypass surgery in heart failure patients with chronic reversible and irreversible myocardial dysfunction: effect on heart rate variability
    Henrik Wiggers
    Department of Cardiology, Skejby Hospital, Aarhus University Hospital, Aarhus, Denmark
    Cardiology 98:181-5. 2002
    ..A potential prognostic benefit gained by revascularizing patients with viability may occur in spite of deteriorated autonomic control of heart rate...
  15. ncbi request reprint Takotsubo cardiomyopathy. An important differential diagnosis to acute myocardial infarction
    Lene Hüche Nielsen
    Department of Cardiology, Vejle Hospital, DK 7100 Vejle, Denmark
    Dan Med Bull 56:165-8. 2009
    ..The purpose of this study was to describe the clinical characteristics and electrocardiographic changes in a Danish cohort of patients with TC. We discuss the potential pathophysiological mechanisms of TC...